To cite this paper use one of the standards below:
Magnetoliposomes (MLs) are nanostructures formed by the incorporation of magnetic nanoparticles (MNPs) into lipid vesicles, combining the superparamagnetic behavior of MNPs with the high biocompatibility and transport capacity of lipid vesicles. These characteristics make MLs highly promising nanostructures for the implementation of innovative strategies for cancer treatment, such as drug delivery, controlled drug release, and magnetic hyperthermia. In this context, this research aims to develop magnetoliposomes for the application of magnetic hyperthermia against breast cancer cells, using an active targeting system based on the exposure of phosphatidylserine on the outer membrane of cancer cells. The efficiency of MNP incorporation into lipid vesicles was evaluated as a function of membrane charge and phase and solution pH, showing a higher incorporation capacity for positively charged membranes and for syntheses conducted in the gel phase of the membrane. Changes in pH were able to alter the incorporation efficiency and hydrodynamic size of the nanoparticles in certain membrane models. Transmission electron microscopy was used to perform a morphological analysis of the MLs and their interaction with cells. Adaptations were made to the MTT assays to enable analysis at high MNP concentrations; the results obtained with HEK293 cells showed cell viability above 90% after 24 h of incubation at MNP concentrations of up to 4 mg/mL. In comparison, in hyperthermia tests, a temperature of 42 °C was reached at an MNP concentration of 500 μg/mL in the presence of a magnetic field of 30 mT and a frequency of 445 kHz. Currently, toxicity tests with breast cancer cells and the incorporation of peptides with affinity for phosphatidylserine into the nanostructures are being performed to evaluate the interaction between the developed MLs and the target cells, as well as the feasibility of the proposed active targeting system.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper